Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
Andrew E. Moran, Michelle C. Odden, Anusorn Thanataveerat, et al.
New England Journal of Medicine (2015) Vol. 372, Iss. 5, pp. 447-455
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Emelia J. Benjamin, Michael J. Blaha, Stephanie E. Chiuve, et al.
Circulation (2017) Vol. 135, Iss. 10
Open Access | Times Cited: 10560
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
Emelia J. Benjamin, Salim S. Virani, Clifton W. Callaway, et al.
Circulation (2018) Vol. 137, Iss. 12
Open Access | Times Cited: 6730
Heart Disease and Stroke Statistics—2016 Update
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, et al.
Circulation (2015) Vol. 133, Iss. 4
Open Access | Times Cited: 6356
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Circulation (2019) Vol. 140, Iss. 11
Open Access | Times Cited: 4195
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Circulation (2019) Vol. 140, Iss. 11
Open Access | Times Cited: 3543
Global Disparities of Hypertension Prevalence and Control
Katherine T. Mills, Joshua D. Bundy, Tanika N. Kelly, et al.
Circulation (2016) Vol. 134, Iss. 6, pp. 441-450
Open Access | Times Cited: 2951
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura, Hisatomi Arima, Shuji Arima, et al.
Hypertension Research (2019) Vol. 42, Iss. 9, pp. 1235-1481
Open Access | Times Cited: 1536
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 10, pp. e177-e232
Open Access | Times Cited: 1490
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 10, pp. 1376-1414
Open Access | Times Cited: 1010
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Dhruv S. Kazi, Andrew E. Moran, Pamela G. Coxson, et al.
JAMA (2016) Vol. 316, Iss. 7, pp. 743-743
Open Access | Times Cited: 336
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage
Alessandro Biffi, Christopher D. Anderson, Thomas W.K. Battey, et al.
JAMA (2015) Vol. 314, Iss. 9, pp. 904-904
Open Access | Times Cited: 236
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
Adam P. Bress, Brandon K. Bellows, Jordan B. King, et al.
New England Journal of Medicine (2017) Vol. 377, Iss. 8, pp. 745-755
Open Access | Times Cited: 218
Hypertension screening, awareness, treatment, and control in India: A nationally representative cross-sectional study among individuals aged 15 to 49 years
Jonas Prenissl, Jennifer Manne‐Goehler, Lindsay M. Jaacks, et al.
PLoS Medicine (2019) Vol. 16, Iss. 5, pp. e1002801-e1002801
Open Access | Times Cited: 185
Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control
Shakia T. Hardy, Laura R. Loehr, Kenneth R. Butler, et al.
Journal of the American Heart Association (2015) Vol. 4, Iss. 10
Open Access | Times Cited: 184
Projected Impact of Mexico’s Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study
Luz María Sánchez‐Romero, Joanne Penko, Pamela G. Coxson, et al.
PLoS Medicine (2016) Vol. 13, Iss. 11, pp. e1002158-e1002158
Open Access | Times Cited: 179
Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults
Rita Hamad, Joanne Penko, Dhruv S. Kazi, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 8, pp. 899-899
Open Access | Times Cited: 133
Exercise and other nonpharmacological strategies to reduce blood pressure in older adults: a systematic review and meta-analysis
P Herrod, Brett Doleman, James Blackwell, et al.
Journal of the American Society of Hypertension (2018) Vol. 12, Iss. 4, pp. 248-267
Open Access | Times Cited: 104
Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review
Luke Robinson, Mitchell Sarkies, Ted Brown, et al.
Injury (2016) Vol. 47, Iss. 12, pp. 2614-2626
Closed Access | Times Cited: 99
Economic burden of vertigo: a systematic review
Éva Kovács, Xiaoting Wang, Eva Grill
Health Economics Review (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 96
Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment
Edo Richard, Susan Jongstra, Hilkka Soininen, et al.
BMJ Open (2016) Vol. 6, Iss. 6, pp. e010806-e010806
Open Access | Times Cited: 88
The antihypertensive potential of flavonoids from Chinese Herbal Medicine: A review
Yi Cao, Long Xie, Kai Liu, et al.
Pharmacological Research (2021) Vol. 174, pp. 105919-105919
Open Access | Times Cited: 85
Hypertension awareness, treatment, and control and their association with healthcare access in the middle-aged and older Indian population: A nationwide cohort study
Jinkook Lee, Jenny Wilkens, Erik Meijer, et al.
PLoS Medicine (2022) Vol. 19, Iss. 1, pp. e1003855-e1003855
Open Access | Times Cited: 56
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
Dongfeng Gu, Jiang He, Pamela G. Coxson, et al.
PLoS Medicine (2015) Vol. 12, Iss. 8, pp. e1001860-e1001860
Open Access | Times Cited: 85
US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future
Lara Kovell, Haitham M. Ahmed, Satish Misra, et al.
Journal of the American Heart Association (2015) Vol. 4, Iss. 12
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top